[go: up one dir, main page]

MD2549F1 - Method of treatment of the chronic viral hepatitis C - Google Patents

Method of treatment of the chronic viral hepatitis C Download PDF

Info

Publication number
MD2549F1
MD2549F1 MD20030180A MD20030180A MD2549F1 MD 2549 F1 MD2549 F1 MD 2549F1 MD 20030180 A MD20030180 A MD 20030180A MD 20030180 A MD20030180 A MD 20030180A MD 2549 F1 MD2549 F1 MD 2549F1
Authority
MD
Moldova
Prior art keywords
treatment
viral hepatitis
chronic viral
glucopyranosyl
day
Prior art date
Application number
MD20030180A
Other languages
Romanian (ro)
Other versions
MD2549G2 (en
Inventor
Constantin Spinu
Tiberiu Holban
Mihai Magdei
Pavel Chintea
Ludmila Birca
Igor Spinu
Original Assignee
Ct Nat Stiintifico Practic De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Nat Stiintifico Practic De filed Critical Ct Nat Stiintifico Practic De
Priority to MDA20030180A priority Critical patent/MD2549G2/en
Publication of MD2549F1 publication Critical patent/MD2549F1/en
Publication of MD2549G2 publication Critical patent/MD2549G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, namely to the internal diseases. Summary of the invention consists in that treatment of the chronic viral hepatitis C includes the symptomatic therapy and an immunomodulating antiviral remedy 5?-furostan-3?,22,26-triol-3-[O-?-D-glucopyranosyl(1?2)-?-D-glucopyranosyl(1?4)-?-D-galactopyranosyl]-26-O-?-D-glucopyranosyl] (pacoverin), applied during 6 months, beginning with the first day of clinical manifestations, in a dose of 50 mg once a day, per os. Claims: 1
MDA20030180A 2003-07-18 2003-07-18 Method of treatment of the chronic viral hepatitis C MD2549G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030180A MD2549G2 (en) 2003-07-18 2003-07-18 Method of treatment of the chronic viral hepatitis C

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030180A MD2549G2 (en) 2003-07-18 2003-07-18 Method of treatment of the chronic viral hepatitis C

Publications (2)

Publication Number Publication Date
MD2549F1 true MD2549F1 (en) 2004-09-30
MD2549G2 MD2549G2 (en) 2005-08-31

Family

ID=33095705

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030180A MD2549G2 (en) 2003-07-18 2003-07-18 Method of treatment of the chronic viral hepatitis C

Country Status (1)

Country Link
MD (1) MD2549G2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD20050015A (en) * 2005-01-14 2006-08-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of diminishing the immune response intensity
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US8809265B2 (en) 2011-10-21 2014-08-19 Abbvie Inc. Methods for treating HCV
US8853176B2 (en) 2011-10-21 2014-10-07 Abbvie Inc. Methods for treating HCV
WO2017189978A1 (en) 2016-04-28 2017-11-02 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3120G2 (en) * 2005-09-15 2007-03-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of influenza prophylaxis
MD3121G2 (en) * 2005-09-15 2007-03-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of viral hepatitis B prophylaxis
MD20060037A (en) * 2006-01-24 2007-07-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treating the acute viral hepatitis C
MD596Z (en) * 2012-10-09 2013-09-30 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for treating chronic viral hepatitis C in children
MD667Z (en) * 2013-03-20 2014-03-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for treatment of infectious mononucleosis in children

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD670G2 (en) * 1996-05-08 1997-08-31 Centrul National Stiintifico-Practic De Igiena Si Epidemiologie Al Ministerului Sanatatii Din Republica Moldova Remedy with immunomodulator activity
MD885G2 (en) * 1996-06-27 1998-08-31 Tatiana Raietchi Method for colitis, hepatitis, pyelonephritis, skin and respiratory tract treatment
MD1875G2 (en) * 1999-11-01 2002-09-30 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the acute viral hepatitis B

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD20050015A (en) * 2005-01-14 2006-08-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of diminishing the immune response intensity
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US8680106B2 (en) 2011-10-21 2014-03-25 AbbVic Inc. Methods for treating HCV
US8685984B2 (en) 2011-10-21 2014-04-01 Abbvie Inc. Methods for treating HCV
US8809265B2 (en) 2011-10-21 2014-08-19 Abbvie Inc. Methods for treating HCV
US8853176B2 (en) 2011-10-21 2014-10-07 Abbvie Inc. Methods for treating HCV
US8969357B2 (en) 2011-10-21 2015-03-03 Abbvie Inc. Methods for treating HCV
US8993578B2 (en) 2011-10-21 2015-03-31 Abbvie Inc. Methods for treating HCV
US9452194B2 (en) 2011-10-21 2016-09-27 Abbvie Inc. Methods for treating HCV
WO2017189978A1 (en) 2016-04-28 2017-11-02 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
US11192914B2 (en) 2016-04-28 2021-12-07 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Also Published As

Publication number Publication date
MD2549G2 (en) 2005-08-31

Similar Documents

Publication Publication Date Title
EP0911033A3 (en) Methods and compositions for the treatment of diseases with interferon while reducing side effects
AR021876A1 (en) COMBINATION THERAPY FOR HCV INDUCTION OF RIBAVIRINA - INTERFERON ALFA PEGILADO
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
MY124853A (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives.
EP2087891A3 (en) Pharmaceutical compositions for treating lymphoma
WO2004045593A3 (en) Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
MD2549F1 (en) Method of treatment of the chronic viral hepatitis C
WO2003063573A3 (en) Method for treating diseases with omega interferon
MD1875F1 (en) Method of treatment of the acute viral hepatitis B
RU2002117537A (en) A method for treating the effects of tissue hypoxia in critically ill patients
DE602005010844D1 (en) PHARMACEUTICAL COMPOSITIONS WITH INTERFERON TAU
MD20060037A (en) Method of treating the acute viral hepatitis C
WO2001045642A3 (en) Pulmonary delivery of ribavirin or levovirin™ for systemic and quasi-systemic treatment of disease
RU2002122053A (en) A method for the treatment of cervical cancer of the IB-II stages
DK1161254T3 (en) Treatment of autoimmune diseases with an extract of American ginseng
IL154299A0 (en) Treatment of hepatitis c with thymosin, interferon and ribavirin
MD2068F1 (en) Method of treatment of the Herpes simplex infection
AU2450900A (en) Therapeutic nucleoside compound
MD1780F1 (en) Method of treatment of patients with hepatic cirrhosis
MD1610F1 (en) Method of the recidivating chronic aphthous stomatitis treatment
RU2002101613A (en) A method for the correction of immuno-and hepatotoxic effects of cyclophosphamide
MXPA05008425A (en) Regimen of administration for nelfinavir.
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
MD1609F1 (en) Method of the recidivating chronic aphthous stomatitis treatment
RU2002109170A (en) A method for the treatment of patients with chronic cerebrovascular diseases

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees